Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

RecruitingPhase 4

Who can join

Ages 18 to 65 · All sexes

Full eligibility criteria

Inclusion Criteria:

* Age 18 to 65 years
* Undergoing ambulatory extended recover (AXR) mastectomy (bilateral or unilateral) at the Josie Robertson Surgical Center (JSRC)

Exclusion Criteria:

* None

About the study

This study aims to assess whether gabapentin should be a standard component of peri-operative pain control in mastectomy patients at Memorial Sloan Kettering Cancer Center.

What is being tested

Modification to Pre-operative Order Set (other)

Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 1,896 · Started: Dec 16, 2025

Contact the study team

James Flory, MD · Phone: 646-608-2914
Andrew Vickers, PhD · Phone: 646-227-3678

Official record on ClinicalTrials.gov — NCT07308717

Locations in the U.S.

New Jersey	Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
New York	Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison Memorial Sloan Kettering Cancer Center, New York Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale

Conditions

Breast Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.